The past couple of weeks in the Alzheimer's world has had its ups and downs. A drug once thought very promising for treatment of Alzheimer's was shown to be ineffective in clinical trials, a discouragement for the scientific community and for all those affected by this disease. On the positive side, the United States launched a draft of the National Plan on Alzheimer's Disease. This is a critical step in the fight against this disease. If you haven't had a chance yet to review and comment on it, I encourage you to take the opportunity to do so; there's more information below.
Dimebon, a drug that has been in phase three of clinical trials for treatment of Alzheimer's disease, has recently been discontinued after studies concluded it was ineffective. Dimebon is a drug that was first used... Read more
This week, the United States' Department of Health & Human Services released its Draft Framework for the National Plan to Address Alzheimer's Disease. This is the nation's first comprehensive plan... Read more